Washington is set to become the first state to offer long-term care benefits for those who pay into the program; a genome-wide polygenic score can predict the odds of obesity; and Montana is moving to reauthorize Medicaid expansion with the addition of community engagement requirements.
Washington is set to become the first state to offer long-term care benefits through an employee-paid program. The program will provide benefits for those who pay into the program, with a lifetime maximum of $36,500 per person, according to the Associated Press. Advocates have applauded the measure, saying that it will help an aging population that is likely not prepared for the increasing costs needed for daily assistance. On the flip side, opponents are calling it an unnecessary intrusion by the government and an additional tax on employees who haven’t had a say on the program.
A genome-wide polygenic score can quantify a person’s inherited susceptibility to obesity, according to a new study published in Cell, which found that the polygenic score effect on weight emerges early in life and increases into adulthood. The researchers validated the predictor, which included 2.1 common variants to determine susceptibility in more than 300,000 individuals ranging from birth to middle age. There was a nearly 30-pound difference between individuals with the highest and lowest scores.After passing in both the House and the Senate, a bill to reauthorize Medicaid expansion in Montana is headed to the governor’s desk for signing. The bill, which reauthorizes expansion until 2025, includes the addition of a required 80 hours of community engagement per month and the removal of a 2.75% tax on Montana State Fund workers compensation programs to help fund the program by taxing hospitals, according to the Great Falls Tribune. More than 96,000 people in the state will benefit from the reauthorized expansion.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512